Archive for the ‘Artificial Intelligence’ Category

The North America artificial intelligence in healthcare diagnosis market is projected to reach from US$ 1,716.42 million in 2019 to US$ 32,009.61…

New York, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Diagnostic Tool ; Application ; End User ; Service ; and Country" - https://www.reportlinker.com/p05974389/?utm_source=GNW

The healthcare industry has always been a leader in innovation.The constant mutating of diseases and viruses makes it difficult to stay ahead of the curve.

However, with the help of artificial intelligence and machine learning algorithms, it continues to advance, creating new treatments and helping people live longer and healthier.A study published by The Lancet Digital Health compared the performance of deep learning a form of artificial intelligence (AI) in detecting diseases from medical imaging versus that of healthcare professionals, using a sample of studies carried out between 2012 and 2019.

The study found that, in the past few years, AI has become more precise in identifying disease diagnosis in these images and has become a more feasible source of diagnostic information.With advancements in AI, deep learning may become even more efficient in identifying diagnosis in the coming years.

Moreover, it can help doctors with diagnoses and notify when patients are weakening so that the medical intervention can occur sooner before the patient needs hospitalization. It can save costs for both the hospitals and patients. Additionally, the precision of machine learning can detect diseases such as cancer quickly, thus saving lives.In 2019, the medical imaging toolsegment accounted for a larger share of the North America artificial intelligence in healthcare diagnosis market. Its growth is attributed to an increasing adoption of AI technology for diagnosis of chronic conditions is likely to drive the growth of diagnostic tool segment in the North America artificial intelligence in healthcare diagnosis.In 2019, the radiology segment held a considerable share of the for North America artificial intelligence in healthcare diagnosis market, by the application. This segment is also predicted to dominate the market by2027 owing to rising demand for AI based application for radiology.A few major primary and secondary sources for the artificial intelligence in healthcare diagnosis market included US Food and Drug Administration, and World Health Organization.Read the full report: https://www.reportlinker.com/p05974389/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Go here to read the rest:
The North America artificial intelligence in healthcare diagnosis market is projected to reach from US$ 1,716.42 million in 2019 to US$ 32,009.61...

With Its Data And Innovation Capabilities, India Can Become Artificial Intelligence Lab Of The World: NITI Aayog CEO – Swarajya

With its data and innovation capabilities, India can become the Artificial Intelligence (AI) laboratory of the world, NITI Aayog CEO Amitabh Kant said on Saturday (3 October).

Speaking at a press conference to unveil the upcoming global virtual summit on AI -- 'RAISE 2020' -- Kant noted that AI can help transform lives.

"India is developing AI-based solutions for social empowerment across spheres like healthcare, education, finance, agriculture and governance. On the strength of its data and innovation prowess, India can become the AI laboratory of the world, delivering intuitive solutions to a wide range of societal issues," he said.

The virtual summit, RAISE 2020 (Responsible AI for Social Empowerment 2020), will be organised from 5-9 October by the Ministry of Electronics and IT and the NITI Aayog.

The aim of the summit is to kick-start discussion on the creation of robust AI-powered public infrastructure that benefits all, not just in India but across the world, an official statement said.

"India, one of the founding members of the Global Partnership on Artificial Intelligence, aims to implement AI-based solutions not just domestically, but in countries around the world so that these lead to widespread social empowerment and prosperity," it said.

Over the course of the five-day summit, several leading AI experts from across the world will deliberate over topics of vital importance such as strategies for using AI for social benefit, the importance of creating reliable AI infrastructure and the transformative effect of AI in empowering communities, it added.

Ajay Prakash Sawhney, Secretary, Ministry of Electronics and IT, said that India has the talent and the institutional capacity to build an AI-ready workforce that innovates and delivers solutions to solve societal issues.

"We are taking steps to promote the development and integration of AI into important spheres of life, in order to improve the ease of living and the overall quality of life. RAISE 2020 will serve as a starting point for India to become a data-driven society that leverages AI for social good," Sawhney said.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

See the rest here:
With Its Data And Innovation Capabilities, India Can Become Artificial Intelligence Lab Of The World: NITI Aayog CEO - Swarajya

Industry VoicesAI doesn’t have to replace doctors to produce better health outcomes – FierceHealthcare

Americans encounter some form of artificial intelligence and machine learning technologies in nearly every aspect of daily life: We accept Netflixs recommendations on what movie we should stream next, enjoy Spotifys curated playlists and take a detour when Waze tells us we can shave eight minutes off of our commute.

And it turns out that were fairly comfortable with this new normal: A survey released last year by Innovative Technology Solutions found that, on a scale of 1 to 10, Americans give their GPS systems an 8.1 trust and satisfaction score, followed closely by a 7.5 for TV and movie streaming services.

But when it comes to higher stakes, were not so trusting. When asked about whether they trust an AI doctor diagnosing or treating a medical issue, respondents scored it just a 5.4.

CMS Doubles Down on CAHPS and Raises the Bar on Member Experience

A new CMS final rule will double the impact of CAHPS and member experience on a Medicare plans overall Star Rating. Learn more and discover how to exceed member expectations and improve Star Ratings in this new whitepaper.

Overall skepticism about medical AI and ML is nothing new. In 2012, we were told that IBMs AI-powered Watson was being trained to recommend treatments for cancer patients. There were claims that the advanced technology could make medicine personalized and tailored to millions of people living with cancer. But in 2018, reports surfaced that indicated the research and technology had fallen short of expectations, leaving users to speculate the accuracy of Watsons predictive analytics.

RELATED:Investors poured $4B into healthcare AI startups in 2019

Patients have been reluctant to trust medical AI and ML out of fear that the technology would not offer a unique or personalized recommendation based on individual needs. A piece in Harvard Business Review in 2019 referenced a survey in which 200 business students were asked to take a free health assessment to perform a diagnosis40% of students signed up for the assessment when told their doctor would perform the diagnosis, while only 26% signed up when told a computer would perform the diagnosis.

These concerns are not without basis. Many of the AI and ML approaches that are being used in healthcare todaydue to simplicity and ease of implementationstrive for performance at the population-level by fitting to the characteristics most common among patients. They look to do well in the general case, failing to serve large groups of patients and individuals with unique health needs. However, this limitation of how AI and ML is being applied is not a limitation of the technology.

If anything, what makes AI and ML exceptionalif done rightis its ability to process huge sets of data comprising a diversity of patients, providers, diseases and outcomes and model the fine-grained trends that could potentially have a lasting impact on a patients diagnosis or treatment options. This ability to use data in the large for representative populations and to obtain inferences in the small for individual-level decision support is the promise of AI and ML. The whole process might sound impersonal or cookie-cutter, but the reality is that the advancements in precision medicine and delivery will make care decisions more data-driven and thus more exact.

Consider a patient choosing a specialist. Its anything but data-driven: Theyll search for a provider in-network or maybe one that is conveniently located, without understanding potential health outcomes as a result of their choice. The issue is that patients lack the proper data and information they need to make these informed choices.

RELATED:The unexpected ways AI is impacting the delivery of care, including for COVID-19

Thats where machine intelligence comes into playan AI/ML model that is able to accurately predict the right treatment, at the right time, by the right provider for a patient, which could drastically help reduce the rate of hospitalizations and emergency room visits.

As an example, research published last month in AJMC looked at claims data from 2 million Medicare beneficiaries between 2017 and 2019 to evaluate the utility of ML in the management of severe respiratory infections in community and post-acute settings. The researchers found that machine intelligence for precision navigation could be used to mitigate infection rates in the post-acute care setting.

Specifically, at-risk individuals who received care at skilled nursing facilities (SNFs) that the technology predicted would be the best choice for them had a relative reduction of 37% for emergent care and 36% for inpatient hospitalizations due to respiratory infections compared to those who received care at non-recommended SNFs.

This advanced technology has the ability to comb through and analyze an individuals treatment needs and medical history so that the most accurate recommendations can be made based on that individuals personalized needs and the doctors or facilities available to them. In turn, matching a patient to the optimal provider has the ability to drastically improve health outcomes while also lowering the cost of care.

We now have the technology where we can use machine intelligence to optimize some of the most important decisions in healthcare. The data show results we can trust.

Zeeshan Syed is the CEO and Zahoor Elahi is the COO of Health at Scale.

Continue reading here:
Industry VoicesAI doesn't have to replace doctors to produce better health outcomes - FierceHealthcare

Artificial Intelligence in Aviation Market 2020 | What Is The Estimated Market Size In The Upcoming Years? – The Daily Chronicle

Market Scenario of the Artificial Intelligence in Aviation Market:

The most recent Artificial Intelligence in Aviation Market Research study includes some significant activities of the current market size for the worldwide Artificial Intelligence in Aviation market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Artificial Intelligence in Aviation-business status, presents volume and worth, key market, product type, consumers, regions, and key players.

Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-68803?utm_source=TDC/komal

The prominent players covered in this report: Boeing, Micron, NVIDIA, Amazon, Airbus, General Electric,Lockheed Martin, Thales, Garmin, Xilinx, and Intel.

The market is segmented into By Offering (Hardware, Software, Service) By Technology (Machine Learning, Context Awareness, NLP, Computer Vision), By Application (Virtual Assistants, Smart Maintenance).

Geographical segments are North America, Europe, Asia Pacific, Middle East & Africa, and South America.

A 360 degree outline of the competitive scenario of the Global Artificial Intelligence in Aviation Market is presented by Quince Market Insights. It has a massive data allied to the recent product and technological developments in the markets.

It has a wide-ranging analysis of the impact of these advancements on the markets future growth, wide-ranging analysis of these extensions on the markets future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-68803?utm_source=TDC/komal

This is anticipated to drive the Global Artificial Intelligence in Aviation Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Artificial Intelligence in Aviation Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Artificial Intelligence in Aviation Market. The feasibility of the new report is also measured in this research report.

Reasons for buying this report:

Make an Enquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-68803?utm_source=TDC/komal

About Us:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [emailprotected]

Web: https://www.quincemarketinsights.com

More here:
Artificial Intelligence in Aviation Market 2020 | What Is The Estimated Market Size In The Upcoming Years? - The Daily Chronicle

Tackling the artificial intelligence IP conundrum – TechHQ

Artificial intelligence has become a general-purpose technology. Not confined to futuristic applications such as self-driving vehicles, it powers the apps we use daily, from navigation with Google Maps to check deposits from our mobile banking app. It even manages the spam filters in our inbox.

These are all-powerful, albeit functional roles. Whats perhaps more exciting is AIs growing potential in sourcing and producing new creations and ideas, from writing news articles to discovering new drugs in some cases, far quicker than teams of human scientists.

With every new iteration in software design, computing power, and ability to leverage large data sets, AIs potential as an initiator of ideas and concepts grow, and this raises questions around its rights to Intellectual Property (IP).

Professor of Law and Health Sciences at the University of Surrey, Dr. Ryan Abbotts work is focused on the meeting of law and technology in particular, the regulation of AI. While Abbott doesnt believe AI should be entitled to its own IP, he believes the time is right to discuss the ability of people to own IP generated autonomously by AI or risk losing out on the technologys full potential.

Right now, we have a system where AI and human activity are treated very differently, Abbott told TechHQ.

Drug discovery is a tangible example of how AI contributes to society. Technology is making the discovery of new drugs faster, cheaper, and more successful. Its been used this way for decades, helping to identify new drug targets or validate drug candidates, and to help design trials in ways that can potentially shorten drug development timeframes, bringing treatments to market faster. But the critical nature of patent protection in life sciences, drug development, in particular, is holding back these advances.

Thats because, when it comes to AI-generated content and ideas, AI tends to be seen by experts and lawmakers as a tool, and not the source of the creation or discovery. In the same way that a paintbrush doesnt get the credit for an oil painting and CAD software isnt credited for the designs of an architect, AI is perceived as a vehicle to an end product. The trouble is, current laws are not consistent and clear cut. In the UK, where a work lacks a traditional human author, the producer of the work is deemed the author. In the US, the inventor is the person who conceives the idea. In either case, neither human may know what the AI system will produce or discover.

While patent rules in life sciences highlight the legal constraints on AI in research and development, these same challenges affect everything from the development of components for cars to spacecraft. The problem will become increasingly apparent as AI continues to improve, and people do not.

The consensus among legal experts is that its not clear whether AI could carry out the understood rights and obligations of an IP owner. IP rights are restricted to natural persons and legal entities such as businesses. The European Union reportedly abandoned plans to introduce a third type of entity electronic personality in 2018 after pressure from 150 experts on AI, robotics, IP, and ethics.

Speaking to Raconteur previously, Julie Barrett-Major, consulting attorney at AA Thornton and member of the Chartered Institute of Patent Attorneys International Liaison Committee, explained: With patent ownership come certain obligations and responsibilities or at least opportunities to exercise these. For example, to enforce the rights awarded, the owner can sue for infringement or at least indicate a willingness to do so to maintain exclusivity.

[] the patent must be renewed at regular intervals, and there are other actions that need to be taken to ensure the rewards are not diluted, such as updating the government registers of patents with details of changes in ownership details, informing of licensees and so forth.

Abbott argues that, ultimately, the limitations of current IP frameworks may force organizations to continue to use people, where a machine might be more efficient.

Last year, Siemens was unable to file for multiple patents on inventions they believed to be patentable because they could not identify a human inventor. The involved engineers stated that the machine did the inventive work. Abbott himself is carrying out a legal test case, filing patents for two inventions made autonomously by AI. Both have been rejected from the US, UK, German, and European patent offices on the basis they failed to disclose a human inventor. The rejections are under appeal, but the idea to help raise dialogue on the issue.

Most of the time today AI is just working as a tool and helping augment people, but machines are getting increasingly autonomous and sophisticated, and increasingly doing the sorts of things that used to make someone an inventor, Abbott said.

The current status quo means that law can get in the way of AI development in certain areas, but not others. That means AIs benefits are not evenly spread across industries. While parents are important to drug development, for example, they are less important when it comes to making software. This imbalance could lead to the emergence of shady IP practices in certain sectors when it comes to using AI. The workaround, says Abbott, is people simply not disclosing AIs role in creating something valuable, whether thats an article, video, or song. Someone can just list themselves as the author and no one is going to question that.

The issue of patents and intellectual property in the fields of academic research, for many of us, might not seem like its worth our consideration. But the broader legal concept Ryan looks to highlight that we should question current standards of AI accountability and ownership affect how AI is being used around us.

Across all areas of the law, we are seeing the phenomenon of artificial intelligence stepping into the shoes of people and doing the sorts of things that people used to do, said Abbott.

Ultimately, for AI to be used to its full potential, there must be an open discussion, public consultation, and debates on the current litigation surrounding AI. Thats now happening. The issue has had recent attention by the World Intellectual Property Organization (WIPO) while the UK Intellectual Property Office just announced a public request for comments on whether the IP system is fit for purpose in light of AI. The US has just completed a similar consultation.

These efforts are a solid start to getting a diverse range of input from stakeholders, said Abbott. In time, legislators should get involved.

Originally posted here:
Tackling the artificial intelligence IP conundrum - TechHQ